Lunai Bioworks LNAI Income Statement (2011-2026)

NASDAQ LNAI
$1.77 -0.07 (-3.54%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Lunai Bioworks Quarterly Income Statement

Periods 59 quarters
Latest Mar 2026

Lunai Bioworks reported revenue of $0.02M and net income of -$1.59M for the quarter ended Mar 2026. This income statement covers 59 quarters of results from Sep 2011 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue
0.02M
Cost of RevenueCost of Rev
Gross Profit
0.02M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
0.03M0.03M0.03M0.03M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
Research & DevelopmentR&D
12.15M3.06M2.34M1.21M1.77M2.61M0.33M0.24M0.99M0.57M0.62M1.09M0.43M0.39M0.16M-0.09M0.08M0.02M0.05M0.02M
Share-based Compensation (IS)Stock Comp.
Selling, General & AdministrativeSG&A
2.01M4.42M3.96M2.79M3.16M4.56M4.01M3.80M2.95M8.29M3.62M7.65M5.00M5.30M4.35M4.22M4.00M2.41M1.77M1.42M
Other Operating ExpensesOther Opex
-12.27M-2.82M0.19M-2.08M7.97M-0.01M0.04M-0.03M781.000.01M-7.29M4.24M9.25M-2.59M4.33M6.89M2.41M1.77M1.42M
Operating ExpensesOpex
14.18M7.50M6.33M4.03M98.21M7.19M4.37M4.06M22.93M8.88M4.27M51.38M17.10M53.34M4.55M4.16M126.92M3.31M1.82M1.45M
Operating IncomeOp. Inc
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
EBIT
-14.18M-7.50M-6.33M-4.03M-98.21M-7.19M-4.37M-4.06M-22.93M-8.88M-4.27M-51.38M-17.10M-53.34M-4.55M-4.16M-126.92M-3.31M-1.82M-1.48M
Non-operating items
Non Operating Interest Expenses
0.10M0.09M0.09M0.10M0.09M0.10M0.09M0.12M0.27M0.18M0.27M0.30M0.25M0.25M0.10M0.19M0.19M0.12M0.12M0.11M
Goodwill impairment chargesGoodwill Impair.
47.61M122.80M
Non Operating Investment IncomeNon-Op. Investment Inc.
0.21M
Interest & Investment IncomeInt & Inv Inc
0.00M0.01M0.01M0.01M0.10M0.01M0.00M0.01M0.13M
Other Non Operating IncomeOther Non Op Inc.
-124.009.00-0.42M0.29M-0.12M-1.30M0.13M72.00-0.02M-6.33M-1.09M
Non Operating IncomeNon Op. Inc.
-3.18M-2.91M-0.25M-2.17M7.97M-0.51M-0.09M-0.26M-0.26M-0.29M-0.26M-7.61M1.37M9.13M-2.71M4.35M0.19M6.13M0.02M-1.14M
Net income details
EBT
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.68M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Tax ProvisionsTaxes
-475.0034.00
Profit After TaxPAT
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.68M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Income from Continuing OperationsIncome (Continuing)
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.55M-51.68M-17.36M-53.46M-4.65M-4.35M-127.11M-3.43M-1.94M-1.59M
Consolidated Net IncomeConsol Net Inc.
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.53M-58.99M-15.73M-44.21M-7.25M0.19M-126.73M2.82M-1.94M-1.59M
Income towards Parent CompanyParent Net Inc
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.53M-58.99M-15.73M-44.21M-7.25M0.19M-126.73M2.82M-1.80M-2.57M
Net Income towards Common StockholdersNet Income
-17.36M-10.41M-6.58M-6.20M-90.24M-7.70M-4.46M-4.33M-23.20M-9.18M-4.53M-58.99M-15.73M-44.21M-7.25M0.19M-126.73M2.82M-1.80M-2.57M
Additional items
EPS (Basic)
-29.45-15.95-10.07-9.42-137.43-11.18-6.42-6.19-32.98-11.38-5.50-43.91-13.08-22.11-3.590.09-61.421.00-0.61-0.82
EPS (Diluted)
-145.70-87.37-55.24-52.04-137.43-11.18-6.42-6.19-32.98-11.38-5.50-43.91-13.08-22.59-3.590.09-61.421.00-0.61-0.82
Shares Outstanding
0.59M0.65M0.65M0.66M0.66M0.69M0.69M0.70M0.70M0.81M0.82M1.34M1.20M2.00M2.02M2.03M2.06M2.82M2.94M3.12M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.12M0.12M0.12M0.12M0.66M0.69M0.69M0.70M0.70M0.81M0.82M1.34M1.20M1.96M2.02M2.05M2.06M2.82M2.94M3.12M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.65M0.65M0.66M0.66M0.66M0.69M0.70M0.72M0.80M0.82M0.84M1.34M1.20M1.97M1.98M2.03M2.22M2.90M3.02M3.12M
EBITDA
-14.15M-7.47M-6.30M-4.00M-98.18M-7.16M-4.34M-4.04M-22.91M-8.86M-4.24M-51.35M-17.07M-53.31M-4.51M-4.13M-126.89M-3.27M-1.81M-1.46M
Interest ExpensesInt Expense
0.10M0.09M0.09M0.10M0.09M0.10M0.09M0.12M0.27M0.18M0.27M0.30M0.25M0.25M0.10M0.19M0.19M0.12M0.12M0.11M

Lunai Bioworks Income Statement API

Pull Lunai Bioworks's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LNAI&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY